Trial Design
The Managing Insulin with Voice AI (MIVA) trial was a remote (decentralized), randomized, open-label, parallel-group clinical trial investigating a novel VBAI application for basal insulin titration compared with standard of care. The trial was conducted at 4 primary care clinics at Stanford University from March 1, 2021, to December 31, 2022. The protocol was approved by the Stanford University institutional review board (trial protocol in 